Gujarat Terce Laboratories Ratios

Gujarat Terce Laboratories Ltd Ratios

The Gujarat Terce Laboratories Ltd Ratios page provides a complete fundamental analysis of Gujarat Terce Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Gujarat Terce Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Gujarat Terce Laboratories Ltd (NSE: , BSE: 524314) is currently trading at ₹38.36, with a market capitalization of ₹298.87M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Gujarat Terce Laboratories Ltd remains a key stock for fundamental analysis using Gujarat Terce Laboratories Ltd Ratios.

Gujarat Terce Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Gujarat Terce Laboratories Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Gujarat Terce Laboratories Ltd Ratios.

Historically, the Gujarat Terce Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 161.43
• 2022: 0
• 2021: 22.24
• 2020: 0

The decline in Gujarat Terce Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Gujarat Terce Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.

Historical P/B trend:

• 2024: 7
• 2023: 5.53
• 2022: 1.80
• 2021: 2.27

Gujarat Terce Laboratories Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Gujarat Terce Laboratories Ltd P/S ratio currently stands at 0.90, an important part of Gujarat Terce Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.90
• 2023: 0.82
• 2022: 0.26
• 2021: 0.48

The rising Gujarat Terce Laboratories Ltd P/S ratio indicates improved revenue valuation by investors.

Gujarat Terce Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Gujarat Terce Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 15.65.

Historical Gujarat Terce Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 15.65
• 2023: 17.64
• 2022: 0
• 2021: 0
• 2020: 0

The declining Gujarat Terce Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Gujarat Terce Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Gujarat Terce Laboratories Ltd EV currently stands at ₹445.19M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 445.19M
• 2023: 430.67M
• 2022: 176.05M
• 2021: 245.67M

Gujarat Terce Laboratories Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Gujarat Terce Laboratories Ltd EV/EBITDA ratio is currently 11.34, a key metric in Gujarat Terce Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 11.34
• 2023: 32.99
• 2022: 0
• 2021: 21.74

Stable Gujarat Terce Laboratories Ltd EV/EBITDA indicates balanced valuation.

Gujarat Terce Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Gujarat Terce Laboratories Ltd D/E ratio is currently 0.15, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.15
• 2023: 0.54
• 2022: 1.06
• 2021: 0.78

Gujarat Terce Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Gujarat Terce Laboratories Ltd ROE currently stands at -14.41%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -14.41
• 2023: 3.48
• 2022: -21.71
• 2021: 10.77

Declining ROE indicates pressure on profitability.

Gujarat Terce Laboratories Ltd Ratios Analysis Summary

The Gujarat Terce Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Gujarat Terce Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Gujarat Terce Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.